The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
Naohisa Hosomi(Hiroshima University), Masayasu Matsumoto, Hideki Origasa(University of Toyama), Tomohisa Nezu(Hiroshima University), Etsuro Mori(The University of Osaka), Shinichiro Uchiyama(International University of Health and Welfare), Yasuo Terayama(Neurology, Inc), Hirofumi Maruyama(Hiroshima University), Toshiho Ohtsuki(The University of Osaka), Chiaki Yokota(National Cerebral and Cardiovascular Center), Takenori Yamaguchi(National Cerebral and Cardiovascular Center), Kazuo Minematsu(Kishokai Medical Corporation), Masanori Fukushima(Nagoya Institute of Technology), Shiro Aoki(Hiroshima University), Kazuo Kitagawa(Tokyo Women's Medical University Hospital), Makoto Takagi(Saiseikai Central Hospital), Yoji Nagai(Translational Research Informatics Center (Japan)), Masakazu Nakamura, Norio Sunami, Setsuro Ibayashi(Kyushu University), Yukito Shinohara(Tachikawa Hospital), Tatsuo Kohriyama(Hiroshima Prefectural Rehabilitation Center)
Cited by 124
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
|The Lancet|2013|3.9k
Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
|The Lancet Global Health|2013|1.3k
‘Ischemic tolerance’ phenomenon found in the brain
|Brain Research|1990|1.1k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823